Cargando…
CCCDTD5: Reducing the risk of later‐life dementia. Evidence informing the Fifth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD‐5)
The Fifth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD‐5) was a year‐long process to synthesize the best available evidence on several topics. Our group undertook evaluation of risk reduction, in eight domains: nutrition; physical activity; hearing; sleep; cogniti...
Autores principales: | Rockwood, Kenneth, Andrew, Melissa K., Aubertin‐Leheudre, Mylène, Belleville, Sylvie, Bherer, Louis, Bowles, Susan K., Kehler, D Scott, Lim, Andrew, Middleton, Laura, Phillips, Natalie, Wallace, Lindsay M.K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656906/ https://www.ncbi.nlm.nih.gov/pubmed/33204818 http://dx.doi.org/10.1002/trc2.12083 |
Ejemplares similares
-
CCCDTD5 recommendations on early non cognitive markers of dementia: A Canadian consensus
por: Montero‐Odasso, Manuel, et al.
Publicado: (2020) -
Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4)
por: Gauthier, Serge, et al.
Publicado: (2012) -
CCCDTD5 recommendations on the deprescribing of cognitive enhancers in dementia
por: Herrmann, Nathan, et al.
Publicado: (2022) -
Canadian Consensus Conference on Diagnosis and Treatment of Dementia (CCCDTD)5: Guidelines for management of vascular cognitive impairment
por: Smith, Eric E., et al.
Publicado: (2020) -
CCCDTD5: research diagnostic criteria for Alzheimer's Disease
por: Gauthier, Serge, et al.
Publicado: (2020)